We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




High Hospital Readmission Rates May Be Misleading

By HospiMedica International staff writers
Posted on 26 Feb 2013
A new study suggests that the standard method used to calculate readmission rates is a misleading indicator of hospital quality.

Researchers at Loyola University Medical Center (LUMC; Proviso, IL, USA) examined the records of 5,780 spine surgery patients treated at the University of California San Francisco Medical Center (USA) between October 2007 and June 2011. More...
Of these, 281 patients (4.9%) were readmitted within 30 days of the previous discharge date. The researchers performed an independent chart review to determine clinically relevant reasons for readmission, and extracted hospital administrative data to calculate direct costs. The researchers then evaluated possible predictors of readmission and the difference in direct cost between readmission and nonreadmission cases.

The results showed that the main reasons for readmission were infection (39.8%), nonoperative management (13.4%), and planned staged surgery (12.4%). Based on the manual chart review, 69 cases (25% of the 281 total readmissions) should be excluded, because 39 cases (13.9%) were planned staged procedures; 16 cases (5.7%) were unrelated to spine surgery; and 14 surgical cases (5.0%) were cancelled or rescheduled at index admission due to unpredictable reasons. When these 69 cases are excluded, the direct cost of readmission was reduced by 29%, representing a cost variance in excess of USD 3 million. The study was published in the February 2013 issue of Journal of Neurosurgery.

“Benchmarking algorithms for defining hospitals' readmission rates must take into account planned staged surgery and eliminate unrelated reasons for readmission,” concluded lead author neurosurgeon Beejal Amin, MD, and colleagues. “When this is implemented in the calculation method, the readmission rate will be more accurate.”

“Current algorithms overestimate clinically relevant readmission rates and cost. This overestimated rate may then be used by payers (that is, Medicare) to deny payment for clinically unavoidable readmissions,” added Dr. Amin. “Developing more sophisticated algorithms with spine surgeons' input will increase the reporting accuracy.”

Medicare (Baltimore, MD, USA) is trying to improve patient care by penalizing hospitals with poor outcomes. One key outcome measure is the readmission rate; one possible result is that Medicare may begin to withhold reimbursements to hospitals with excessively high readmission rates.

Related Links:

Loyola University Medical Center
University of California San Francisco Medical Center
Medicare




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.